Chanda Sanjay
- SEC CIK
- 0001571820
In the past year, 1 open-market sale filing worth $9.31K and no purchases.
Current role at each company
- ANTX AN2 Therapeutics, Inc.Chief Development Officeras of Mar 23, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $9.31K
- 1 filing
- Net
- −$9.31K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Chanda Sanjay as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 (view filing) | Jan 5-6 | 2 days | Chanda SanjayChief Development Officer | SSale | −9.25K | $1.01 | −$9.31K | −10.9%75.8K after | 2 lots |
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | Chanda SanjayChief Development Officer | SSale | −2.96K | $1.34 | −$3.96K | −9.0%29.8K after |